Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ioversol
Drug ID BADD_D01186
Description Ioversol is classified as an _organoiodine_ compound and is used as a contrast dye in diagnostic procedures. It contains high levels of iodine in addition to various hydrophilic groups.
Indications and Usage Optiray 240 is indicated for cerebral angiography and venography. Optiray 240 is also indicated for contrast enhanced computed tomographic imaging of the head and body and intravenous excretory urography.
Marketing Status Prescription; Discontinued
ATC Code V08AB07
DrugBank ID DB09134
KEGG ID D01555
MeSH ID C054871
PubChem ID 3741
TTD Drug ID D0U1ZD
NDC Product Code 0019-1323; 0019-1333; 57884-0015; 0019-1332; 67684-8777; 0406-7888
Synonyms ioversol | Optiray 320 | Optiray | Optiray 300
Chemical Information
Molecular Formula C18H24I3N3O9
CAS Registry Number 87771-40-2
SMILES C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acidosis14.01.03.002--
Agitation17.02.05.012; 19.06.02.001--
Amnesia17.03.02.001; 19.20.01.001--
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anaphylactic shock10.01.07.002; 24.06.02.004--Not Available
Angina pectoris02.02.02.002; 24.04.04.002--
Angioedema10.01.05.009; 23.04.01.001--Not Available
Anoxia22.02.02.009--Not Available
Anuria20.01.03.002--Not Available
Anxiety19.06.02.002--
Aortic valve stenosis02.07.03.004--Not Available
Aphasia17.02.03.001; 19.21.01.001--
Apnoea22.02.01.001--
Arrhythmia02.03.02.001--Not Available
Arterial spasm24.04.02.011--Not Available
Arterial thrombosis24.01.01.002--Not Available
Arteriosclerosis24.04.02.001--Not Available
Arteriovenous fistula24.03.03.001--Not Available
Asthma10.01.03.010; 22.03.01.002--Not Available
Atrioventricular block02.03.01.002--Not Available
Blindness06.02.02.001; 17.17.01.003--Not Available
Blindness cortical06.02.02.004; 17.17.01.017--Not Available
Blood pressure abnormal13.14.03.001--Not Available
Blood pressure fluctuation24.06.01.002--Not Available
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Bronchospasm10.01.03.012; 22.03.01.004--
Bundle branch block02.03.01.009--Not Available
Cardiac arrest02.03.04.001--
Cardiac failure02.05.01.001--
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene